A.CairnsB
The benefits to health have led to the approval of semaglutide for treating kidney and heart fibrosis in the US, but the treatment potential is much wider, opening possibilities for treating cancer, psoriasis, polycystic ovary syndrome, sinus disease, obstructive sleep apnoea, Alzheimers, Parkinsons, liver disease, atherosclerosis (vascular disease) [6], asthma, some forms of nerve damage [2] and more
Skipping or switching doses without a physicians input can damage progress and cause additional side effects
In conclusion, GLP-1 RAs provide an important therapeutic option for patients with T2D to improve glucose control, mitigate cardiovascular and kidney risk, and facilitate weight loss
Prescription levocarnitine (brand name Carnitor) is an MHRA-licensed medicine used only for confirmed primary or secondary carnitine deficiency under medical supervision, and it is not licensed for weight loss